Insider sales are routine option-exercise tax-withholding transactions. Do not read bearish signal. Monitor upcoming quarterly earnings (likely August 2026) for pipeline progress on Tyvaso and any clinical data readouts, those are the material catalysts for UTHR, not this cluster.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 4 $547.22entry
- T+1 · 6mo ago −0.16%α +2.44% · $546.37
- T+5 · 5mo ago −0.33%α +2.22% · $545.40
- T+20 · 4mo ago +1.59%α +3.21% · $555.91
- T+60 · 3mo ago −6.15%α −7.77% · $513.54
Price Chart
How similar events traded
Executive Summary
CEO Martine Rothblatt and CFO James Edgemond sold a combined ~$1.41M in UTHR shares over five trading days, entirely from exercised options. These are routine same-day stock-for-tax sales (cashless exercises), not open-market liquidation of unrestricted shares. At 0.006% of UTHR's $22.9B market cap, the dollar value is trivial and carries no informational signal. The cross-filing actuarial verdicts show near-uniform amplification for this combo type, but the standalone economics of these sales are too small to warrant an impact override.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 2,820 shares total at ~$535-562 over 3 trading days, all from option exercises at exercises at $0 and $146.03 per share.
- CFO James Edgemond sold 3,200 shares total at ~$545-561 over 2 trading days, all from option exercises at exercises at $0 and $117.76 per share.
- Total open-market sale proceeds: ~$2.5M (includes proceeds from shares sold same-day as option exercise). Net cash received by insiders after strike costs: ~$1.41M.
- All sales are same-day sale-to-cover transactions from option exercise, routine tax-withholding pattern, not discretionary portfolio liquidation.
- Total sale value is 0.006% of UTHR's $22.9B market cap, economically trivial.
Financial Impact
Total open-market sales proceeds of ~$1.41M (net of strike costs), 0.006% of market cap. Trivial.
Risk Factors
- CEO Rothblatt sold shares at an average of ~$545, near 52-week highs, but the pattern is consistent with her regular option-exercise cadence.
- No open-market purchases alongside these sales to offset selling signal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1780518915452 |
Track record
123 reports on UTHR
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers